GENEVA, Feb. 26 -- ADARX PHARMACEUTICALS, INC. (5871 Oberlin DriveSuite 200San Diego, CA 92121) filed a patent application (PCT/US2024/042783) for "MODIFIED OLIGONUCLEOTIDES CONTAINING MULTIPLE OLIGONUCLEOTIDES" on Aug 16, 2024. With publication no. WO/2025/038970, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhen (c/o Adarx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), ZHU, Rui (c/o Adarx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), CHIRUTA, Chandramouli (c/o Ad...